SCHEMBL1719006

SCHEMBL1719006

COc1cc(NC(=O)c2nn3c(C(F)(F)F)cc(-c4ccccc4)nc3c2Cl)c(OC)cc1Cl

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.62
TP53 P04637 2/20 0.58
PTGES O14684 1/20 0.55
POLB P06746 1/20 0.54
ALDH1A1 P00352 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
HPGD P15428 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
USP2 O75604 1/20 0.54
MAPK1 P28482 1/20 0.53
RXFP1 Q9HBX9 3/20 0.52
THRB P10828 1/20 0.52
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719021 0.92 RXFP1 (0.60) MAPTTP53PTGESPOLBALDH1A1
SCHEMBL1719819 0.92 PTGES (0.66) MAPTTP53PTGESPOLBALDH1A1
SCHEMBL1719273 0.90 MAPT (0.62) MAPTPTGESALDH1A1CYP1A2CYP3A4
SCHEMBL1720004 0.89 HPGD (0.59) MAPTTP53PTGESPOLBALDH1A1
SCHEMBL1719847 0.85 MAPT (0.66) MAPTPTGESALDH1A1CYP1A2CYP3A4
SCHEMBL1718225 0.84 TP53 (0.78) MAPTTP53POLBALDH1A1CYP1A2
SCHEMBL1718851 0.84 MAPT (0.68) MAPTPTGESALDH1A1CYP1A2CYP3A4
SCHEMBL1718513 0.84 MAPT (0.64) MAPTTP53PTGESALDH1A1CYP1A2
SCHEMBL1718509 0.83 MAPT (0.64) MAPTTP53PTGESALDH1A1CYP1A2
SCHEMBL1718229 0.83 MAPT (0.64) MAPTPTGESALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed